Roxanne Martino - Ventas Independent Director
| VTR Stock | USD 64.54 0.29 0.45% |
Director
Ms. Roxanne M. Martino is Independent Director of the Company. She has served as President and then CEO of Aurora Investment Management fundoffunds since 1990. Over nearly three decades, Ms. Martino built the Chicago firm into one of the largest managers in the fundoffunds industry, managing 14 billion at Aurora peak. In 2012 Aurora won Hedge Funds Reviews Best Diversified Fund of Hedge Funds over 10 years. Prior to joining Aurora, Ms. Marino was a trailblazer in fundoffunds as a General Partner in Grosvenor Capital Management. She began her career at Coopers Lybrand. Ms. Martino holds an MBA in 1988 from the University of Chicago and graduated in 1977 with a BBA from University of Notre Dame since 2016.
| Age | 63 |
| Tenure | 8 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Ventas Management Efficiency
The company has Return on Asset of 0.0175 % which means that on every $100 spent on assets, it made $0.0175 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/29/2024, Return On Tangible Assets is likely to grow to -0.0016. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Asset Turnover is relatively stable compared to the past year.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Burke Whitman | Omega Healthcare Investors | 64 | |
| Charlotte Swafford | National Health Investors | 73 | |
| Robert Adams | National Health Investors | 74 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Robert McCabe | National Health Investors | 70 | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Matthew Cypher | Global Medical REIT | 44 | |
| Paula Crowley | Global Medical REIT | 66 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| James Morey | Universal Health Realty | 52 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
| Kimberly Ouimet | National Health Investors | N/A | |
| Colleen Schaller | National Health Investors | N/A | |
| Ronald Marston | Global Medical REIT | 78 | |
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Robert Webb | National Health Investors | 76 | |
| Dana Hambly | National Health Investors | N/A | |
| Peter Lyle | Healthcare Realty Trust | 56 | |
| James Jobe | National Health Investors | 59 | |
Management Performance
| Return On Equity | -0.0054 | ||||
| Return On Asset | 0.0175 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Justin Hutchens, Executive Officer | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0054 | ||||
| Return On Asset | 0.0175 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 39.85 B | ||||
| Shares Outstanding | 419.51 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 98.51 % | ||||
| Number Of Shares Shorted | 21.48 M | ||||
| Price To Earning | 909.80 X |
Pair Trading with Ventas
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ventas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventas will appreciate offsetting losses from the drop in the long position's value.Moving against Ventas Stock
| 0.56 | RC | Ready Capital Corp | PairCorr |
| 0.49 | INN | Summit Hotel Properties | PairCorr |
| 0.38 | PW | Power REIT | PairCorr |
| 0.36 | PK | Park Hotels Resorts | PairCorr |
| 0.32 | FR | First Industrial Realty | PairCorr |
The ability to find closely correlated positions to Ventas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ventas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ventas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ventas Inc to buy it.
The correlation of Ventas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ventas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ventas Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ventas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Ventas Stock Analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.